Gide has developed a highly recommended practice in securities law and mergers & acquisitions for listed companies in all markets in which it is present.
At times involved from the very creation of stock markets in drafting the rules applicable to stock market transactions (such as in Poland), and thereby creating and upholding close ties with market authorities, Gide has been instructed on major transactions on markets such as France, China, Morocco, Poland, Hungary and Russia.
Our practice covers both friendly and hostile takeover bids for originators, targets and white knights alike, and any related disputes.
SIPH: counsel to Michelin on the Société Internationale de Plantations d'Hévéas (SIPH) cash tender offer.
Debiopharm / Gecina Eurosic: advising Debiopharm Holding, shareholder of Eurosic, in the context of the friendly business combination between Gecina and Eurosic consisting in the acquisition of all securities of Eurosic by Gecina. This transaction was supported by Eurosic's six main shareholders (Batipart, Covea, ACM, Predica, Debiopharm and La Tricogne) representing 94.8% of its capital.
Silic: advising Silic on its amalgamation with Icade (CDC).
Compagnie la Lucette: advising Morgan Stanley Real Estate Fund MSREF on the sale of its 94.5% participation in the capital of Compagnie la Lucette to Icade, and on the acquisition of a 4.5% stake in Icade.
Geodis: advising SNCF Participations on its public bid offer on the capital of its subsidiary Geodis.
Quadra FNX: advising KGHM Polska Miedz SA, Polish leader on the extraction of copper and silver for Toronto-listed mining company Quadra FNX.
Supor: advising SEB on the acquisition from SU Family of a major stake in the capital of Zhejiang, listed on the Shenzhen stock exchange, and on the acquisition of an additional shareholding.